Faralli et al. (127) in their study of 536 patients, found vascular comorbidities including hypertension, hyperlipidaemia, dyslipidaemia, ischemic heart disease and stroke increased the need for more than one CRP session, with those having multiple vascular comorbidities requiring significantly higher number of treatment sessions. The gene discussed is CRP; the disease is hypertensive disorder.